Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 4/20 | 0.64 |
| ▸ | ABCB1 | P08183 | 3/20 | 0.53 |
| ▸ | CREB1 | P16220 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.49 |
| ▸ | MAPT | P10636 | 5/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 7/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | XDH | P47989 | 2/20 | 0.44 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4173907 | 0.91 | CYP3A4 (0.54) | ADORA3ABCB1KDM4EMAPTALDH1A1 | |
| SCHEMBL28428273 | 0.89 | ADORA3 (0.67) | ADORA3ABCB1CREB1KDM4EMAPT | |
| SCHEMBL4157325 | 0.83 | ABCB1 (0.76) | ADORA3ABCB1KDM4EMAPTALDH1A1 | |
| SCHEMBL28421208 | 0.82 | ADORA3 (0.74) | ADORA3ABCB1CREB1KDM4EMAPT | |
| SCHEMBL4160600 | 0.81 | ADORA3 (0.52) | ADORA3ABCB1CREB1KDM4EMAPT | |
| SCHEMBL4156024 | 0.81 | ADORA3 (0.56) | ADORA3ABCB1KDM4EMAPTALDH1A1 | |
| SCHEMBL28410849 | 0.80 | ADORA3 (0.79) | ADORA3ABCB1CREB1KDM4EMAPT | |
| SCHEMBL28417080 | 0.79 | ADORA3 (0.70) | ADORA3ABCB1CREB1KDM4EMAPT | |
| SCHEMBL1664667 | 0.78 | ADORA3 (1.00) | ADORA3ABCB1CREB1KDM4EMAPT | |
| SCHEMBL4169488 | 0.77 | ADORA3 (0.48) | ADORA3ABCB1MAPTALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090130051-A1 | Flavonoid Compounds and Uses Thereof | HOWARD FLOREY INSTITUTE OF EXPERIMENTAL PHYSIOLOGY AND MEDICINE (AU) | 2009-05-21 | — | — | US | claimed |
| CN-107801402-B | Composition for diagnosing skin damage caused by mote and composition comprising galangin as effective ingredient | 株式会社爱茉莉太平洋 | 2022-03-11 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090130051-A1 | Flavonoid Compounds and Uses Thereof | CAT, NQO1, GPX4 | ADORA3 2776/4885ABCB1 1605/4885CREB1 3943/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.